imiquimod has been researched along with Lupus Nephritis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Fujishiro, M; Hayakawa, K; Ikeda, K; Kataoka, Y; Morimoto, S; Nishi, T; Sakuma, S; Sekigawa, I; Takamori, K; Yoshida, Y | 1 |
| Horiba, N; Kato, A; Kito, A; Murai, A; Nishihara, K; Oyama, S; Yamazaki, M | 1 |
| Ahmed, SA; Cecere, T; Cowan, C; Dai, R; Edwards, MR; Heid, B; Werre, SR | 1 |
| Bai, X; Gong, L; Wang, Y; Wu, S; Zhou, L; Zhu, F; Zhu, YF | 1 |
| Anders, HJ; Kretzler, M; Patole, PS; Pawar, RD; Schlöndorff, D; Segerer, S; Zecher, D | 1 |
| Anders, HJ; Ellwart, A; Lech, M; Patole, PS; Pawar, RD; Schlondorff, D; Segerer, S | 1 |
| Anders, HJ; Kulkarni, OP; Lech, M; Pawar, RD; Ramanjaneyulu, A; Segerer, S | 1 |
7 other study(ies) available for imiquimod and Lupus Nephritis
| Article | Year |
|---|---|
Exposure of female NZBWF1 mice to imiquimod-induced lupus nephritis at an early age via a unique mechanism that differed from spontaneous onset.
Topics: Animals; Autoimmunity; Female; Imiquimod; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Mice; Signal Transduction; Toll-Like Receptor 7 | 2022 |
Class II lupus nephritis with podocyte injury in imiquimod-induced lupus-prone mice.
Topics: Animals; Complement C1q; Female; Imiquimod; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Podocytes; Toll-Like Receptor 7 | 2022 |
Low-dose 17α-ethinyl estradiol (EE) exposure exacerbates lupus renal disease and modulates immune responses to TLR7/9 agonists in genetically autoimmune-prone mice.
Topics: Animals; Autoantibodies; Blood Urea Nitrogen; Creatinine; Cytokines; Ethinyl Estradiol; Female; Imiquimod; Immune Complex Diseases; Immunoglobulin G; Kidney Glomerulus; Leukocytes; Lupus Nephritis; Membrane Glycoproteins; Mice; Mice, Inbred MRL lpr; Proteinuria; Spleen; Toll-Like Receptor 7; Toll-Like Receptor 9 | 2020 |
Activation of toll-like receptor-7 exacerbates lupus nephritis by modulating regulatory T cells.
Topics: Aminoquinolines; Animals; Cytokines; Dendritic Cells; Female; Imiquimod; Kidney; Ligands; Lupus Nephritis; Lymphocyte Activation; Membrane Glycoproteins; Mice, Inbred C57BL; Phenotype; T-Lymphocytes, Regulatory; Toll-Like Receptor 7 | 2014 |
Toll-like receptor-7 modulates immune complex glomerulonephritis.
Topics: Aminoquinolines; Animals; Antibody Formation; Antigen-Antibody Complex; Cells, Cultured; Chemokine CCL2; Female; Glomerulonephritis; Imiquimod; Immune Complex Diseases; Inflammation Mediators; Interleukin-12; Interleukin-6; Lupus Nephritis; Macrophages; Membrane Glycoproteins; Mice; Mice, Inbred MRL lpr; RNA, Messenger; Toll-Like Receptor 7 | 2006 |
Ligands to nucleic acid-specific toll-like receptors and the onset of lupus nephritis.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Autoantibodies; B-Lymphocytes; Cytokines; Dendritic Cells; DNA, Bacterial; Female; Imiquimod; Immunoglobulin G; Interferon Inducers; Interferon-alpha; Interleukin-12 Subunit p40; Interleukin-6; Lupus Nephritis; Lymphocyte Activation; Mice; Poly I-C; Spleen; Toll-Like Receptors | 2006 |
Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Autoantibodies; Female; Genetic Therapy; Imiquimod; Interleukin-6; Kidney; Lupus Nephritis; Membrane Glycoproteins; Mice; Mice, Inbred MRL lpr; Monocytes; Oligodeoxyribonucleotides; Respiratory Distress Syndrome; Signal Transduction; Spleen; Toll-Like Receptor 7; Toll-Like Receptor 9; Tumor Necrosis Factor-alpha | 2007 |